BioWorld MedTech

May 31, 2012

The MDD Interview: Hoping that benefits, needs can carry the day for new products

Robert Ward is chairman of Emergence Venture Partners, president of ExThera Medical (both Berkeley, California), and founder and former president of the Polymer Technology Group (PTG), now DSM Biomedical. Read More

ViewRay gains clearance for MRI guided radiation therapy system

Washington roundup: House passes FDA user fee legislation with voice vote

Agreements/contracts: Spacelabs provides solutions to Texas hospital department

Financings roundup: Kona Medical raises $30M in 'C' round of financing

Patents roundup: Miracor strengthens patent protection for PICSO in U.S.

International report: Symmetry to drive expansion in Australia and New Zealand

Product Briefs

HIT roundup: HL7 recruiting physicians to bolster EHR standards

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...